Susan G Komen  
I've Been Diagnosed With Breast Cancer Someone I Know Was Diagnosed Share Your Story Join Us And Stay Informed Donate To End Breast Cancer
Home > Research & Grants > Brinker Awards > Congratulations to the 2013 Brinker Awardees

  


Congratulations to the 2013 Brinker Awardees


 

Congratulations to the 2013 Brinker Awardees

Congratulations to our 2013 Brinker Awardees! These prominent physician-scientists are honored for their groundbreaking work which has developed treatments and tailored therapies for breast cancer patients. They will deliver keynote lectures December 11 at the 36th annual San Antonio Breast Cancer Symposium, a major international gathering of breast cancer researchers, clinicians, and patient advocacy organizations from around the world being held Dec. 10-14 in San Antonio, Texas.
 
Perez1 

 Edith A. Perez, M.D. 

Mayo Clinic Cancer Center

Jacksonville, Florida

 

 

Dr. Edith A. Perez is receiving the Brinker Award for Scientific Distinction in Clinical Research for her seminal impactful contributions to the field of breast cancer treatment, which have helped to shape the standard of care for breast cancer patients globally. Dr. Perez has devoted her career to improving breast cancer patient care and expanding the understanding of breast cancer biology. She has led a wide range of translational clinical trials testing new therapeutic agents for the treatment and prevention of breast cancer---trials that have had a lasting impact on women facing a breast cancer diagnosis. Read her full bio here.

 

Mills
 

Gordon B. Mills, M.D., Ph.D. 

M.D. Anderson Cancer Center

Houston, Texas

 
 

Dr. Gordon B. Mills is receiving the Brinker Award for Scientific Distinction in Basic Science for his significant contributions to breast cancer research, which have been essential to advancing our understanding of the key processes that drive breast cancer's initiation, progression and response to therapy. Dr. Mills has championed a cancer systems biology approach to understand the impact of genomic aberrations on complex signaling networks at the proteomic (protein) level, with the goal of individualizing cancer diagnosis and treatment. Read his full bio here.